Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers C > Headlines for Clarus Therapeutics Holdings, Inc. > News item |
Clarus Therapeutics reports $832,376 net loss for November
Chicago, Dec. 22 – Clarus Therapeutics Holdings, Inc. debtor Clarus Therapeutics, Inc. reported a $832,376 net loss on zero gross income/sales for November, according to its monthly operating report filed with the U.S. Bankruptcy Court for the District of Delaware.
General and administrative expenses accounted for the loss.
The cash balance at the end of the month was $6.15 million versus $14.85 million at the end of October.
The Northbrook, Ill.-based pharmaceutical company filed bankruptcy under Chapter 11 on Sept. 5. The case number is 22-10845.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.